170 related articles for article (PubMed ID: 22552009)
1. Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma.
Yonglitthipagon P; Pairojkul C; Bhudhisawasdi V; Mulvenna J; Loukas A; Sripa B
Clin Biochem; 2012 Jul; 45(10-11):827-34. PubMed ID: 22552009
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.
Yonglitthipagon P; Pairojkul C; Chamgramol Y; Loukas A; Mulvenna J; Bethony J; Bhudhisawasdi V; Sripa B
Hum Pathol; 2012 Oct; 43(10):1719-30. PubMed ID: 22446018
[TBL] [Abstract][Full Text] [Related]
3. A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.
Shi Y; Deng X; Zhan Q; Shen B; Jin X; Zhu Z; Chen H; Li H; Peng C
J Gastrointest Surg; 2013 Sep; 17(9):1584-91. PubMed ID: 23868055
[TBL] [Abstract][Full Text] [Related]
4. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
[TBL] [Abstract][Full Text] [Related]
5. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
[TBL] [Abstract][Full Text] [Related]
6. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
[TBL] [Abstract][Full Text] [Related]
7. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.
Chua-On D; Proungvitaya T; Techasen A; Limpaiboon T; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sungkhamanon S; Proungvitaya S
Tumour Biol; 2016 Oct; 37(10):13659-13667. PubMed ID: 27473083
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients.
Cavalloni G; Peraldo-Neia C; Massa A; Bergamini C; Trentini A; De Rosa G; Daniele L; Ciccosanti F; Cervellati C; Leone F; Aglietta M
BMC Cancer; 2021 Jul; 21(1):865. PubMed ID: 34320944
[TBL] [Abstract][Full Text] [Related]
10. USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma.
Xu X; Chen Y; Shao S; Wang J; Shan J; Wang Y; Wang Y; Chang J; Zhou T; Chen R; Liu S; Li C; Li C; Li X
Int J Biol Sci; 2024; 20(4):1492-1508. PubMed ID: 38385089
[TBL] [Abstract][Full Text] [Related]
11. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
[TBL] [Abstract][Full Text] [Related]
12. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
[TBL] [Abstract][Full Text] [Related]
13. A novel TFF2 splice variant (∆EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma.
Kamlua S; Patrakitkomjorn S; Jearanaikoon P; Menheniott TR; Giraud AS; Limpaiboon T
Oncol Rep; 2012 Apr; 27(4):1207-12. PubMed ID: 22159958
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
16. Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma.
Rucksaken R; Pairojkul C; Pinlaor P; Khuntikeo N; Roytrakul S; Selmi C; Pinlaor S
PLoS One; 2014; 9(7):e103259. PubMed ID: 25058392
[TBL] [Abstract][Full Text] [Related]
17. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
Zhou Z; Ma J
Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
[TBL] [Abstract][Full Text] [Related]
18. ALCAM is a Novel Cytoplasmic Membrane Protein in TNF-α Stimulated Invasive Cholangiocarcinoma Cells.
Adisakwattana P; Suwandittakul N; Petmitr S; Wongkham S; Sangvanich P; Reamtong O
Asian Pac J Cancer Prev; 2015; 16(9):3849-56. PubMed ID: 25987048
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of cholangiocarcinoma cell line.
Srisomsap C; Sawangareetrakul P; Subhasitanont P; Panichakul T; Keeratichamroen S; Lirdprapamongkol K; Chokchaichamnankit D; Sirisinha S; Svasti J
Proteomics; 2004 Apr; 4(4):1135-44. PubMed ID: 15048994
[TBL] [Abstract][Full Text] [Related]
20. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY
Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
